Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on Invested CapitalReturn on Sales

Dr Reddys Laboratories (RDY) Invested Capital (2016 - 2025)

Historic Invested Capital for Dr Reddys Laboratories (RDY) over the last 16 years, with Q4 2025 value amounting to $564.7 million.

  • Dr Reddys Laboratories' Invested Capital changed N/A to $564.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 11830.64%. This contributed to the annual value of $5.4 billion for FY2025, which is 2267.84% up from last year.
  • According to the latest figures from Q4 2025, Dr Reddys Laboratories' Invested Capital is $564.7 million.
  • Dr Reddys Laboratories' 5-year Invested Capital high stood at $4.4 billion for Q1 2024, and its period low was $80.8 million during Q3 2023.
  • Moreover, its 5-year median value for Invested Capital was $417.0 million (2021), whereas its average is $955.7 million.
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 8860.08% in 2021, then skyrocketed by 70807.98% in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Invested Capital stood at $284.7 million in 2021, then tumbled by 50.94% to $139.7 million in 2022, then tumbled by 42.14% to $80.8 million in 2023, then skyrocketed by 490.56% to $477.3 million in 2024, then rose by 18.31% to $564.7 million in 2025.
  • Its last three reported values are $564.7 million in Q4 2025, $481.3 million for Q3 2025, and $1.4 billion during Q1 2025.